Contact with contaminated surfaces or an infected person can readily spread the sickness, which is the most common infectious cause of vomiting and diarrhea.
In the UK, norovirus is responsible for roughly 80 fatalities and 12,000 hospital admissions annually.
According to experts, Moderna’s novel mRNA vaccine may prevent the virus from infecting humans.
With the expectation that 2,500 people will sign up before the end of December, 27 NHS hospitals and centers in England, Scotland, and Wales are now participating in a trial.
Over the course of about 25 months, volunteers will be monitored and half will take the vaccine and the other half a dummy medication.
Researchers anticipate that the jab will be at least 65% effective.
According to the study’s main investigator, Dr. Patrick Moore, there are presently “no approved vaccines for norovirus anywhere in the world” and hospital patients can only receive intravenous fluids as treatment.
It produces diarrhea and vomiting, usually for two to three days, he continued. Although norovirus is prevalent throughout the year, it often peaks in the UK during the winter and can afflict people of all ages.
